Gina Massa Mias
Compliance Officer chez ESBATech, a Novartis Co. GmbH
Profil
Ms. Gina M.
Mias is a Principal at Novartis AG and Head-Finance & Compliance Officer at ESBATech AG.
She received her undergraduate degree from the University of Massachusetts and an MBA from the University of Massachusetts.
Postes actifs de Gina Massa Mias
| Sociétés | Poste | Début |
|---|---|---|
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Compliance Officer | - |
Anciens postes connus de Gina Massa Mias
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Formation de Gina Massa Mias
| University of Massachusetts | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |